Cresols
eMolecules ChemScene / 4-Bromo-35-dimethylphenylboronic acid / 500mg / 632344475 / CS-0189824 / 0.000 / 1451391-45-9 / MFCD23713094 / 228.880 / C8H10BBrO2
ChemScene / 4-Bromo-35-dimethylphenylboronic acid / 500mg / 632344475 / CS-0189824 / 0.000 / 1451391-45-9 / MFCD23713094 / 228.880 / C8H10BBrO2
Aobchem 3-(2 4 6-Trimethoxyphenyl)-2-propenoic acid | ≥97% | CAS 13063-09-7 | C12H14O5 | 1g
3-(2 4 6-Trimethoxyphenyl)-2-propenoic acid | ≥97% | CAS 13063-09-7 | C12H14O5 | 1g
Aobchem 2-Bromo-3-methylphenol | ≥95% | CAS 22061-78-5 | C7H7BrO | 10g
2-Bromo-3-methylphenol | ≥95% | CAS 22061-78-5 | C7H7BrO | 10g
Aobchem 2-Bromo-3-methylphenol | ≥95% | CAS 22061-78-5 | C7H7BrO | 25g
2-Bromo-3-methylphenol | ≥95% | CAS 22061-78-5 | C7H7BrO | 25g
eMolecules 185739-14-4 | 2,2-Difluoroethenyl 4-methylbenzene-1-sulfonate | Ambeed | MFCD27946567 | 234.220 | C9H8F2O3S | 95.000 | Cc1ccc(cc1)S(=O)(=O)OC=C(F)F | 100mg | 672837923
2,2-Difluoroethenyl 4-methylbenzene-1-sulfonate | Ambeed | 185739-14-4 | MFCD27946567 | 234.220 | C9H8F2O3S | 95.000 | Cc1ccc(cc1)S(=O)(=O)OC=C(F)F | 100mg | 672837923
eMolecules 123-11-5 | p-Anisaldehyde | Chem-Impex | MFCD00003385 | 136.150 | C8H8O2 | 98.000 | COc1ccc(C=O)cc1 | 25g | 490847545
p-Anisaldehyde | Chem-Impex | 123-11-5 | MFCD00003385 | 136.150 | C8H8O2 | 98.000 | COc1ccc(C=O)cc1 | 25g | 490847545
eMolecules 123-11-5 | p-Anisaldehyde | Chem-Impex | MFCD00003385 | 136.150 | C8H8O2 | 98.000 | COc1ccc(C=O)cc1 | 100g | 490847546
p-Anisaldehyde | Chem-Impex | 123-11-5 | MFCD00003385 | 136.150 | C8H8O2 | 98.000 | COc1ccc(C=O)cc1 | 100g | 490847546
Medchemexpress LLC JIB-04 | 199596-05-9 | 98.3% | 308.76 | 1 ML
JIB-04 is a pan-selective Jumonji histone demethylase inhibitor. It exhibits IC50s of 230, 340, 855, 445, 435, 1100, and 290 nM for JARID1A, JMJD2E, JMJD3, JMJD2A, JMJD2B, JMJD2C, and JMJD2D, respectively. It is intended for research use only.
- Is consistently selective for cancer versus normal cells.
- Inhibits cellular Jumonji demethylase activity.
- Significantly inhibits the proliferation of glioblastoma cell lines.
- Exerts maximal inhibitory activity against KDM5A.
- Modulates the expression of genes involved in cancer cell growth.
- Leads to hypermethylation of H3K4.
- Activates autophagy and apoptotic pathways.
- Inactivates PI3K.
- Cooperates with temozolomide in killing glioblastoma cells.
- Results in a significant reduction in cancer-induced death rates in mice, prolonging survival.
Medchemexpress LLC M-PEG12-azide | 2170098-29-8 | >98.6% | C25H51N3O12 | 5 G
m-PEG12-azide is a PEG-based PROTAC linker designed for use in the synthesis of PROTACs. It functions as a click chemistry reagent, featuring an Azide group that facilitates various conjugation reactions.
- PEG-based PROTAC linker
- Used in the synthesis of PROTACs
- Click chemistry reagent with an Azide group
- Undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAc) with Alkyne groups
- Engages in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups
Akina Inc Poly(lactide-co-glycolide)-b-Poly(ethylene glycol)-b-Poly(lactide-co-glycolide) (per g)
PLGA-PEG-PLGA (Mw ~1,700:1,500:1,700 Da) LA:GA 3:1 Poly(lactide-co-glycolide)-b-Poly(ethylene glycol)-b-Poly(lactide-co-glycolide) (per g)
Medchemexpress LLC Methoxy polyethylene glycol (mPEG) 13 carboxylic acid | 2170098-33-4 | MFCD28385486 | 95.0% | 632.74 g/mol | C28H56O15 | 1 G
m-PEG13-acid is a methoxy-terminated polyethylene glycol (PEG) linker bearing a terminal carboxylic acid. It is used as a flexible, hydrophilic spacer for bioconjugation and PEGylation; the carboxylic acid can be activated for amide formation with primary amines, making it suitable for linker construction in medicinal chemistry and PROTAC synthesis.
- Provides terminal carboxylic acid for facile amide coupling to primary amines
- Methoxy-terminated (monofunctional) PEG to limit crosslinking
- Flexible, hydrophilic spacer suitable for PEGylation and linker design
- Molecular weight ≈ 632.74 g/mol; formula C28H56O15
- Common applications include bioconjugation and PROTAC linker synthesis
- Supplied as a powder; follow supplier storage and handling guidance
Medchemexpress LLC BirA protein, E. coli (His-MBP tag) | >95.0% | 100 UG
Recombinant BirA protein expressed in Escherichia coli with N-terminal 6xHis and MBP fusion tags. Supplied lyophilized for biochemical and biotinylation assays, it provides high purity and measurable enzymatic activity for consistent site-specific protein biotinylation.
- N-terminal 6xHis and MBP fusion tags for purification and solubility.
- Supplied lyophilized in stabilizing excipients for storage and transport.
- Purity >95.0% as determined by reducing SDS-PAGE.
- Recommended reconstitution to ≥100 μg/mL for activity assays.
- Specific activity >100 pmol/min/μg for efficient biotinylation.
- Store at -20°C and aliquot for long-term stability.
Cayman Chemical p-Cresol GlucuronIde 1mg
A metabolite of p-cresol; formed from p-cresol primarily by UGT1A6, but also by UGT1A9, in human liver and kidney microsomes; accumulates in feces, blood, and urine of patients with CKD